Literature DB >> 16106358

Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA.

Nils Hackstein1, Hendrik Kooijman, Stefan Tomaselli, Wigbert S Rau.   

Abstract

We determined the optimum gadolinium (Gd)-DTPA dose and time window for calculating the glomerular filtration rate (GFR) using contrast-enhanced (CE) dynamic MRI and the Patlak plot technique. Twelve adult volunteers with healthy kidneys were included in the study. As a reference method the GFR was measured by iopromide plasma clearance. A three-dimensional gradient-echo (GRE) sequence with a flip angle of 50 degrees was used for MRI. Signal was measured using a body surface coil with four elements. Each volunteer was examined on four days using 2 mL, 4 mL, 8 mL, or 16 mL of Gd-DTPA 0.5 mmol/mL dissolved with sodium chloride (NaCl) 0.9% to a total of 60 mL. The injection rate was 1 mL/second. A Patlak plot was calculated from the kidney and aorta signals. The mean reference GFR was 133 mL/min (min-max, 116-153 mL/min). The best correlation of GFR calculated from MRI data compared to the reference method was found in a time window 30-90 seconds after aortic signal rise using 16 mL Gd-DTPA. Pearson's correlation coefficient was r = 0.83, and the standard deviation (SD) from the line of regression was 10.5 mL/minute. We found a significantly lower average GFR(MR) using 16 mL Gd-DTPA compared to 4 mL and 2 mL in the late time window 60-120 seconds post aortic rise. A dose of 16 mL Gd-DTPA was optimal for measuring GFR using dynamic MRI and the Patlak plot technique. The slope should be measured in a time window of 30-90 seconds post aortic rise. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106358     DOI: 10.1002/jmri.20401

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

Review 1.  Pediatric uroradiology: state of the art.

Authors:  Kassa Darge; J Damien Grattan-Smith; Michael Riccabona
Journal:  Pediatr Radiol       Date:  2010-04-21

Review 2.  [Functional magnetic resonance imaging of the kidneys].

Authors:  R S Lanzman; M Notohamiprodjo; H J Wittsack
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

Review 3.  MR urography in children.

Authors:  J Damien Grattan-Smith; Richard A Jones
Journal:  Pediatr Radiol       Date:  2006-06-22

4.  Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model.

Authors:  Jeff L Zhang; Henry Rusinek; Louisa Bokacheva; Lilach O Lerman; Qun Chen; Chekema Prince; Niels Oesingmann; Ting Song; Vivian S Lee
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

5.  Modeling systemic and renal gadolinium chelate transport with MRI.

Authors:  John R Votaw; Diego Martin
Journal:  Pediatr Radiol       Date:  2007-12-11

6.  Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients.

Authors:  Jeff L Zhang; Henry Rusinek; Louisa Bokacheva; Ruth P Lim; Qun Chen; Pippa Storey; Keyma Prince; Elizabeth M Hecht; Danny C Kim; Vivian S Lee
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

7.  MR urography in children: how we do it.

Authors:  J Damien Grattan-Smith; Stephen B Little; Richard A Jones
Journal:  Pediatr Radiol       Date:  2007-12-11

8.  Functional immunoassay technology (FIT), a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR).

Authors:  Christopher Peter Reinhardt; Michael J Germain; Ernest V Groman; Jeffrey G Mulhern; Rajesh Kumar; Dennis E Vaccaro
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-03

9.  Functional analysis in MR urography - made simple.

Authors:  Dmitry Khrichenko; Kassa Darge
Journal:  Pediatr Radiol       Date:  2009-12-12

Review 10.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.